Acquisition Context ProSolus was acquired by Canoa Supply, enabling access to a broader pharma network for transdermal product development and manufacturing. Sales opportunities include tapping Canoa's customer base for joint development contracts, scaling manufacturing, and expanding into new geographic markets through a joint go to market strategy.

Transdermal Expertise ProSolus focuses on patient centered transdermal patches and collaborates with strategic suppliers to optimize absorption using polymers and excipients without exotic permeation enhancers. Positioning as a specialized contract development and manufacturing organization for high barrier transdermal products, ProSolus can offer end to end services from formulation through manufacturing along with regulatory support.

Small Team Capacity With a lean team and a state of the art facility in Miami, ProSolus can provide nimble, high touch partnerships and fast start up cycles. Sales opportunities include serving as a preferred contract manufacturer for mid sized pharma seeking pilot scale runs and scalable manufacturing agreements, as well as joint development projects.

Strategic Partnerships R and D teams collaborate with strategic suppliers to design polymer and excipient combinations that improve absorption. Opportunities include partnering with large pharma or contract manufacturers to add specialized transdermal capabilities and to cross sell within the Canoa network.

Polymer Formulation Edge ProSolus emphasizes polymer and excipient driven formulations to enhance skin absorption without relying on exotic permeation enhancers. Opportunities include licensing formulation know how for custom patches, white label manufacturing, and co development programs.